Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Franklin Genomic Advancements Fund I (acc) USD Fonds 113697904 / LU2387456598

5.97 USD
0.02 USD
0.34 %
14.2.2025
NAV

Nettoinventarwert (NAV)

5.97 USD 0.02 USD 0.34 %
Vortag 5.95 USD Datum 14.02.2025

Franklin Genomic Advancements Fund I (acc) USD Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Ripple XRP ETP CH0454664043 212.77%
21Shares Stellar ETP CH1109575535 156.35%
21Shares The Sandbox ETP CH1177361008 134.26%
21Shares Decentraland ETP USD Accumulation CH1161102699 76.29%
21Shares Sui Staking ETP CH1360612159 10.58%
21Shares Immutable ETP CH1360612142 -32.17%
21Shares Injective Staking ETP CH1360612134 -34.88%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 368.90%
21Shares Sui Staking ETP CH1360612159 301.18%
21Shares Stellar ETP CH1109575535 255.29%
21Shares Aave ETP CH1135202120 152.30%
21Shares Algorand ETP CH1146882316 151.33%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Injective Staking ETP CH1360612134 -17.01%
21Shares Immutable ETP CH1360612142 -31.65%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 386.22%
21Shares Stellar ETP CH1109575535 196.41%
21Shares Aave ETP CH1135202120 178.49%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 149.98%
21Shares Crypto Mid-Cap Index ETP CH1130675676 95.88%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 831.10%
21Shares Ripple XRP ETP CH0454664043 571.54%
21Shares Bitcoin Core ETP CH1199067674 323.04%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 312.47%
21Shares Bitcoin ETP CH0454664001 312.30%

Fundamentaldaten

Valor 113697904
ISIN LU2387456598
Emittent Franklin Templeton International Services
Aufgelegt in Luxembourg
Auflagedatum 15.10.2021
Kategorie Branchen: Gesundheitswesen
Währung USD
Volumen 3’200’331.23
Depotbank J.P. Morgan SE, Luxembourg Branch
Geschäftsjahresende 30.06.
Berichtsstand 13.02.2025

Anlagepolitik

So investiert der Franklin Genomic Advancements Fund I (acc) USD Fonds: The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.

ETP Performance: Franklin Genomic Advancements Fund I (acc) USD Fonds

Performance 1 Jahr
-4.17
Performance 2 Jahre
-4.94
Performance 3 Jahre
-20.82
Performance 5 Jahre -
Performance 10 Jahre -